Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney M Campbell

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Future Cardiology|December 12, 2019
Optimizer Smart in the treatment of moderate-to-severe chronic heart failureCourtney M Campbell, Rami Kahwash, William T Abraham
European Heart Journal. Case Reports|May 1, 2020
Atypical haemolytic uraemic syndrome: a case report of a rare cause of reversible cardiomyopathyCourtney M Campbell, Clarissa Cassol, Spero R Cataland, et al.
The American Journal of Medicine|January 25, 2022
Developing Therapy for Transthyretin AmyloidosisCourtney M Campbell, Kathleen Zhang, Daniel J Lenihan, et al.
Journal of Clinical Medicine|September 16, 2020
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic ReviewCourtney M Campbell, Avirup Guha, Tamanna Haque, et al.
Journal of the American Heart Association|April 26, 2021
Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac AmyloidosisDaniel Addison, Jeremy A Slivnick, Courtney M Campbell, et al.
Journal of the American Heart Association|July 28, 2020
Cardio-Oncology in the Era of the COVID-19 Pandemic and BeyondDaniel Addison, Courtney M Campbell, Avirup Guha, et al.
Circulation. Arrhythmia and Electrophysiology|September 6, 2013
Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillationCourtney M Campbell, Jonathan D Campbell, Christopher H Thompson, et al.
Cardio-Oncology (London, England)|October 23, 2021
Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemiaLisa Kim, Brian Fowler, Courtney M Campbell, et al.
Journal of the American Heart Association|June 22, 2022
Quantification of Cardiac Adipose Tissue in Failing and Nonfailing Human MyocardiumKyra K Peczkowski, Mohammed A Mashali, Nancy S Saad, et al.
Frontiers in Neurology|November 7, 2022
Multidisciplinary amyloidosis care in the era of personalized medicineNaresh Bumma, Rami Kahwash, Samir V Parikh, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Future Cardiology|December 12, 2019
Optimizer Smart in the treatment of moderate-to-severe chronic heart failureCourtney M Campbell, Rami Kahwash, William T Abraham
European Heart Journal. Case Reports|May 1, 2020
Atypical haemolytic uraemic syndrome: a case report of a rare cause of reversible cardiomyopathyCourtney M Campbell, Clarissa Cassol, Spero R Cataland, et al.
The American Journal of Medicine|January 25, 2022
Developing Therapy for Transthyretin AmyloidosisCourtney M Campbell, Kathleen Zhang, Daniel J Lenihan, et al.
Journal of Clinical Medicine|September 16, 2020
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic ReviewCourtney M Campbell, Avirup Guha, Tamanna Haque, et al.
Journal of the American Heart Association|April 26, 2021
Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac AmyloidosisDaniel Addison, Jeremy A Slivnick, Courtney M Campbell, et al.
Journal of the American Heart Association|July 28, 2020
Cardio-Oncology in the Era of the COVID-19 Pandemic and BeyondDaniel Addison, Courtney M Campbell, Avirup Guha, et al.
Circulation. Arrhythmia and Electrophysiology|September 6, 2013
Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillationCourtney M Campbell, Jonathan D Campbell, Christopher H Thompson, et al.
Cardio-Oncology (London, England)|October 23, 2021
Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemiaLisa Kim, Brian Fowler, Courtney M Campbell, et al.
Journal of the American Heart Association|June 22, 2022
Quantification of Cardiac Adipose Tissue in Failing and Nonfailing Human MyocardiumKyra K Peczkowski, Mohammed A Mashali, Nancy S Saad, et al.
Frontiers in Neurology|November 7, 2022
Multidisciplinary amyloidosis care in the era of personalized medicineNaresh Bumma, Rami Kahwash, Samir V Parikh, et al.
Pageof 3